newsfilter
← Latest News
GlobeNewswire·

Vaxxinity Joins TransCelerate Research and Development Consortium

CAPE CANAVERAL, Fla., March 21, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ:VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, announced today that it has joined